Zhejiang Jolly Pharmaceutical Co., Ltd. (300181.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 13.27

From 52W high−26.88%

Volume6.39M

Market capCNY 9.80B

P/E (TTM)15.5x

P/S (TTM)3.0x

Div yield2.63%

Key dataSep 18, 2026

Open

CNY 13.27

From 52W high

−26.88%

Volume

6.39M

Market cap

CNY 9.80B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.1x

P/E (TTM)

15.5x

RSI (14)

41.2

MomentumView details →

1D Return

−1.20%

YTD Return

−17.70%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

15.5x

EV/EBITDA

11.1x

EV/Sales

3.0x

P/S (TTM)

3.0x

P/B (TTM)

3.1x

ProfitabilityView details →

Gross Margin

62.43%

Net Margin

20.88%

EBITDA Margin

27.20%

ROE (TTM)

18.99%

ROA (TTM)

12.20%

Asset Turnover

0.62x

GrowthView details →

Revenue YoY

+14.10%

EPS YoY

+19.28%

FCF YoY

+412.52%

Revenue CAGR 3Y

+18.98%

EPS CAGR 3Y

+26.92%

EBITDA YoY

—

MomentumView details →

1D Return

−1.20%

YTD Return

−17.70%

1Y Return

−24.60%

RSI (14)

41.2

vs 50D SMA

−5.51%

vs 200D SMA

−13.14%

Capital & dividendView details →

Debt/Equity

0.22x

Current Ratio

1.55x

Quick Ratio

1.21x

Div Yield

2.63%

Div Rate

CNY 0.35

Div Growth 1Y

−41.67%

EarningsView details →

EPS (Actual)

CNY 0.26

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−1.10%

Financials snapshotView financials →

Revenue (TTM)

3.11B

Net Income (TTM)

650.37M

Op. CF (TTM)

569.25M

Latest newsMore news →

Zhejiang Jolly Pharmaceutical reported 2026 H1 revenue of RMB 1.764 billion (+10.30% YoY) and net profit attributable to shareholders of RMB 375 million (+0.38% YoY).8d ago

Zhejiang Jolly Pharmaceutical announced a cash dividend of 3.5 yuan per 10 shares (tax inclusive) for the 2026 first half, with no capital reserve conversion to share capital.24d ago

Similar companies

豪恩汽电301488.SZ 天康生物002100.SZ 利安隆300596.SZ 冠捷科技000727.SZ 匠心家居301061.SZ 达利凯普301566.SZ Find similar companies →

Latest newsMore news →

Zhejiang Jolly Pharmaceutical reported 2026 H1 revenue of RMB 1.764 billion (+10.30% YoY) and net profit attributable to shareholders of RMB 375 million (+0.38% YoY).8d ago Zhejiang Jolly Pharmaceutical announced a cash dividend of 3.5 yuan per 10 shares (tax inclusive) for the 2026 first half, with no capital reserve conversion to share capital.24d ago